HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Okumura Selected Research

4,4-diphenyl-2-cyclopentenylamine

12/2000Asymmetric synthesis and determination of the absolute configuration of FK584, an agent for the treatment of overactive detrusor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Okumura Research Topics

Disease

20Neoplasms (Cancer)
02/2012 - 01/2000
9Inflammation (Inflammations)
11/2011 - 07/2000
6Atopic Dermatitis (Atopic Eczema)
06/2011 - 02/2002
6Hypertension (High Blood Pressure)
03/2004 - 02/2000
5Asthma (Bronchial Asthma)
06/2011 - 07/2000
4Graft vs Host Disease (Graft-Versus-Host Disease)
01/2015 - 04/2000
4Carcinoma (Carcinomatosis)
02/2012 - 03/2001
4Hypersensitivity (Allergy)
09/2009 - 01/2001
4Necrosis
02/2009 - 12/2001
4Neoplasm Metastasis (Metastasis)
03/2001 - 10/2000
3Glomerulonephritis
11/2011 - 02/2001
3Leukemia
12/2006 - 08/2000
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2001 - 11/2000
2Psoriasis (Pustulosis Palmaris et Plantaris)
12/2022 - 12/2007
2Shock
01/2018 - 04/2002
2Hypertriglyceridemia
06/2013 - 06/2001
2Body Weight (Weight, Body)
06/2013 - 04/2001
2Lymphoma (Lymphomas)
02/2012 - 07/2000
2Insulin Resistance
02/2012 - 03/2004
2Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
06/2011 - 01/2009
2Bronchiolitis Obliterans Syndrome
06/2010 - 11/2001
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
09/2009 - 12/2001
2Ischemia
02/2008 - 01/2000
2Infections
12/2007 - 11/2001
2Type 2 Diabetes Mellitus (MODY)
03/2004 - 11/2003
2Colitis
10/2003 - 04/2003
2Cardiomegaly (Heart Hypertrophy)
12/2001 - 09/2001
2Fatty Liver
12/2001 - 09/2001
2Atrial Fibrillation
10/2001 - 02/2001
2Coronary Artery Disease (Coronary Atherosclerosis)
06/2001 - 04/2001
2Myocardial Infarction
05/2001 - 02/2001
2Hyperplasia
04/2001 - 02/2001
2Ventricular Tachycardia
04/2001 - 01/2000
2Essential Hypertension
02/2000 - 01/2000
1Seasonal Allergic Rhinitis (Hay Fever)
03/2015
1Allergic Rhinitis
03/2015
1Cytokine Release Syndrome
01/2015
1Skin Diseases (Skin Disease)
10/2014
1Hyperinsulinism (Hyperinsulinemia)
06/2013
1Squamous Cell Carcinoma of Head and Neck
11/2012
1Hypoxia (Hypoxemia)
11/2012
1Darier Disease (Darier's Disease)
05/2012
1T-Cell Lymphoma (Lymphoma, T Cell)
02/2012

Drug/Important Bio-Agent (IBA)

16LigandsIBA
11/2011 - 01/2001
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008 - 08/2000
7Monoclonal AntibodiesIBA
10/2003 - 09/2000
6CytokinesIBA
01/2015 - 07/2000
5ChemokinesIBA
10/2014 - 08/2001
5Fas Ligand Protein (Fas Ligand)IBA
10/2003 - 08/2000
5Interleukin-12 (IL 12)IBA
11/2001 - 06/2000
4Pharmaceutical PreparationsIBA
02/2012 - 01/2000
4Proteins (Proteins, Gene)FDA Link
11/2011 - 01/2000
4Immunoglobulin E (IgE)IBA
06/2011 - 09/2000
4IgE Receptors (Fc epsilon RI)IBA
04/2010 - 09/2000
4Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2009 - 02/2000
4TNF-Related Apoptosis-Inducing LigandIBA
01/2009 - 11/2000
3Insulin (Novolin)FDA Link
06/2013 - 01/2000
3Triglycerides (Triacylglycerol)IBA
06/2013 - 06/2001
3EnzymesIBA
02/2012 - 03/2001
3SaltsIBA
02/2012 - 01/2000
3AntigensIBA
05/2007 - 07/2000
3Fatty Acids (Saturated Fatty Acids)IBA
03/2005 - 01/2000
3InterferonsIBA
12/2001 - 03/2001
3PerforinIBA
11/2001 - 01/2001
3Transforming Growth Factor beta (TGF-beta)IBA
09/2001 - 07/2000
3alpha-galactosylceramideIBA
09/2001 - 07/2000
3OX40 LigandIBA
02/2001 - 01/2000
2FibrinolysinFDA Link
01/2015 - 02/2012
2Glucose (Dextrose)FDA LinkGeneric
06/2013 - 03/2004
2Peptides (Polypeptides)IBA
02/2012 - 02/2001
2F(6) ATPaseIBA
02/2012 - 10/2001
2Toll-Like Receptors (Toll-Like Receptor)IBA
11/2011 - 11/2001
2Peptide Hydrolases (Proteases)FDA Link
09/2009 - 02/2001
2CaspasesIBA
01/2008 - 06/2000
2NF-kappa B (NF-kB)IBA
01/2008 - 11/2001
2Death Domain ReceptorsIBA
05/2007 - 12/2006
2Therapeutic UsesIBA
10/2003 - 04/2003
2Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2002 - 03/2001
2Niacin (Nicotinic Acid)FDA LinkGeneric
10/2001 - 06/2000
2picolinic acid (chromium picolinate)IBA
10/2001 - 06/2000
2Vasoconstrictor AgentsIBA
10/2001 - 11/2000
2Daunorubicin (Cerubidine)FDA LinkGeneric
09/2001 - 02/2000
24-1BB Ligand (4 1BB Ligand)IBA
05/2001 - 12/2000
2AutoantibodiesIBA
09/2000 - 03/2000
1BetacellulinIBA
12/2022
1Anesthetics (Anesthetic Agents)IBA
01/2018
1AllergensIBA
03/2015
1S100 Calcium Binding Protein A7IBA
10/2014
1CholesterolIBA
06/2013
1gosha-jinki-ganIBA
06/2013
1Radiation-Protective Agents (Radiation Protectants)IBA
11/2012
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2012
1Antifibrinolytic Agents (Antifibrinolytics)IBA
02/2012
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
02/2012
1Br-DIF-1IBA
02/2012
1Stem Cell FactorIBA
02/2012

Therapy/Procedure

10Therapeutics
02/2012 - 01/2000
2Stem Cell Transplantation
02/2012 - 06/2010
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2000 - 04/2000